Four previously tested AI diagnostic algorithms for skin cancer demonstrated lower sensitivity and specificity when tested on ...

"As previously announced, we intend to significantly increase our electricity generation activities in Italy by incrementally building and commissioning a solar energy production portfolio, with the ...

Shares of Castle Biosciences Inc (NASDAQ:CSTL) rose 7.8% after the company announced that its DecisionDx-Melanoma test has ...

It’s the most commonly diagnosed cancer in the U.S. and one in five in this country will develop skin cancer at some point in ...

Castle Biosciences' DecisionDx-Melanoma test and Revolution Medicines' elironrasib cancer drug receive FDA Breakthrough Designations. Read more here.

The Mole Mobile is coming to Parksville. The mobile skin cancer screening unit on wheels is back in British Columbia and will ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

WWE Hall of Famer Ric Flair is cancer free once again. Flair announced on Tuesday that he's completed his treatment for melanoma. Per TMZ, it was his second battle with skin cancer within the last ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

Teddi Mellencamp seemed to address a report of an alleged attempted burglary at her home in LA. Read on for details.

When it comes to living in a high-sun state like Arizona, a simple skin check can mean the difference between life and death ...

BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the ...